Trifecta Capital Advisors, LLC Merck & Co., Inc. Transaction History
Trifecta Capital Advisors, LLC
- $506 Billion
- Q4 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 9,665 shares of MRK stock, worth $902,227. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,665
Previous 30,753
68.57%
Holding current value
$902,227
Previous $3.49 Billion
72.47%
% of portfolio
0.19%
Previous 0.73%
Shares
7 transactions
Others Institutions Holding MRK
# of Institutions
3,968Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.3 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.54 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.71 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $236B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...